Advanced search
Publication Cover
Acta Oto-Laryngologica Volume 142, 2022 - Issue 1
Submit an article Journal homepage
178
Views
0
CrossRef citations to date
0
Altmetric
Oncology

Gene mutations and clinical prognosis of mucosal melanoma in different locations of head and neck

Wei Guoa Beijing Tongren Hospital, Capital Medical University, Beijing, China
,
Gaofei Yina Beijing Tongren Hospital, Capital Medical University, Beijing, ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-9512-4118
ORCID Icon,
Chuanliang Cuib The Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital and Institute, Beijing, China
,
Yan Kongb The Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital and Institute, Beijing, China
,
Zhigang Huanga Beijing Tongren Hospital, Capital Medical University, Beijing, China
&
Xiaohong Chena Beijing Tongren Hospital, Capital Medical University, Beijing, ChinaCorrespondence[email protected]
Pages 94-99 | Received 05 Oct 2021, Accepted 11 Nov 2021, Published online: 26 Dec 2021

References

  • Chi Z, Li S, Sheng X, et al. Clinical presentation, histology, and prognoses of malignant melanoma in ethnic Chinese: a study of 522 consecutive cases. BMC Cancer. 2011;11(1):85.
  • Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132.
  • Cui C, Lian B, Zhou L, et al. Multifactorial analysis of prognostic factors and survival rates among 706 mucosal melanoma patients. Ann Surg Oncol. 2018;25(8):2184–2192.
  • Mallone S, De Vries E, Guzzo M, et al. Descriptive epidemiology of malignant mucosal and uveal melanomas and adnexal skin carcinomas in Europe. Eur J Cancer. 2012;48(8):1167–1175.
  • Clifton N, Harrison L, Bradley PJ, et al. Malignant melanoma of nasal cavity and paranasal sinuses: Report of 24 patients and literature review. J Laryngol Otol. 2011;125(5):479–485.
  • Yin G, Guo W, Chen X, et al. Clinical characteristic and prognostic analyses of 117 cases of head and neck mucosal melanoma. Chin J Otorhinolaryngol Head Neck Surg. 2018;53(9):668–674.
  • Lund VJ, Chisholm EJ, Howard DJ, et al. Sinonasal malignant melanoma: an analysis of 115 cases assessing outcomes of surgery, postoperative radiotherapy and endoscopic resection. Rhinology. 2012;50(2):203–210.
  • Lian B, Si L, Cui C, et al. Phase II randomized trial comparing high-dose IFN-alpha2b with temozolomide plus cisplatin as systemic adjuvant therapy for resected mucosal melanoma. Clin Cancer Res. 2013;19(16):4488–4498.
  • Newell F, Kong Y, Wilmott JS, et al. Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets. Nat Commun. 2019;10(1):3163.
  • Bai X, Kong Y, Chi Z, et al. MAPK pathway and TERT promoter gene mutation pattern and its prognostic value in melanoma patients: a retrospective study of 2,793 cases. Clin Cancer Res. 2017;23(20):6120–6127.
  • Reyes E, Uribe C, de Vries E. Population-based incidence and melanoma-specific survival of cutaneous malignant melanoma in a Colombian population 2000-2009. Int J Dermatol. 2018;57(1):21–27.
  • Zhang T, Dutton-Regester K, Brown KM, et al. The genomic landscape of cutaneous melanoma. Pigment Cell Melanoma Res. 2016;29(3):266–283.
  • Hayward NK, Wilmott JS, Waddell N, et al. Whole-genome landscapes of major melanoma subtypes. Nature. 2017;545(7653):175–180.
  • Zhou R, Shi C, Tao W, et al. Analysis of mucosal melanoma whole-genome landscapes reveals clinically relevant genomic aberrations. Clin Cancer Res. 2019;25(12):3548–3560.
  • Nassar KW, Tan AC. The mutational landscape of mucosal melanoma. Semin Cancer Biol. 2020;61:139–148. Apr
  • Cancer genome atlas network. Genomic classification of cutaneous melanoma. Cell. 2015;161(7):1681–1696.
  • Nazarian R, Shi H, Wang Q, et al. Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK OR N-RAS upregulation. Nature. 2010;468(7326):973–977. doi:https://doi.org/10.1038/nature09626.
  • Flaherty KT, Puzanov I, Kim KB, et al. Inhibition of mutated, activated BRAF in metastatic melanoma. N Engl J Med. 2010;363(9):809–819. doi:https://doi.org/10.1056/NEJMoa1002011.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.